STOCKscreener 
 .  i  n  f  o 
                
NOVARTIS R
 Login   Help  
 
    
 Home 
 About   News 
 Indices 2017 
 Market News 
 Company News 
 Performance 
 Momentum 
 All Time Highs 
 Trading Systems 
 The STOCK BLOCK 
 Links 
 
 Impressum 
 
 
big chart
 
max chart6 months chartbig chart
 
 
Last closing price:   CHF 82.05 (2017-12-07) -0.55 %

Ticker: NOVN.VTX,   ISIN: CH0012005267     (watch)

P/E: 18.69,   P/B: 4.09,   ROE: 21.88 %,   ROA: 11.38 %,   Market cap:   CHF 188'468'850'000.00,   EV:   159'584'070'000.00,   EV/EBIT:   13.07,   ROC:   51.30 %

http://www.novartis.com/ (IR, RSS, calendar) - latest presentation/quarterly report/annual report

SWX, UBS Quotes, ZKB, Comdirect, Yahoo (chart), Google Finance/News

News

 Novartis drug Afinitor┬« gains EU approval to treat patients with advanced pancreatic neuroendocrine tumors 2011-09-05 
 Novartis International BioCamp spotlights how diversity spurs innovation across the company and inspires future science leaders 2011-08-29 
 FDA requests additional clinical data on Novartis drug ACZ885 for the treatment of gouty arthritis 2011-08-29 

Calendar

 2010-07-15 Second quarter and first half 2010 results 
 2010-10-21 Third quarter and first nine months 2010 results 
Performance
2017 10.73 %
2016 -14.63 %
2015 -6.01 %
2014 29.71 %
2013 23.93 %
2012 7.08 %
2011 -2.37 %
2010 -2.74 %
2009 7.21 %
2008 -15.14 %
2007 -11.60 %
2006 1.74 %
2005 20.51 %
2004 2.05 %
2003 11.30 %
2002 -15.92 %
 
Compounded annual gain: 1.98 %
Overall gain: 36.75 %
 
All time high (2015-07-20): 102.30  
Current drawdown: -19.79 %
Compare with 200 trading days moving average trading system.

Download historical prices from Yahoo

 
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice.
Impressum